The NCRI Brain Group brings together clinicians, scientists and lay representatives, amongst many others, to coordinate the development of a strategic portfolio of research within the field of brain tumours. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for brain tumour patients.  

The NCRI Brain Group consists of an executive group, chaired by Professor Michael Jenkinsonwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Brain Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive group and subgroups twice a year.  

Group Chair: Professor Michael Jenkinson

Usama Ali

Thomas Booth, Consultant Diagnostic & Interventional Neuroradiologist, King’s College Hospital NHS Foundation Trust

Sebastian Brandner, Pathologist, University College London (UCL)

Juliet Brock, Consultant Clinical Oncologist, Brighton and Sussex University Hospitals NHS Trust

Helen Bulbeck, NCRI Consumer Forum Member, Brainstrust

Sara Erridge, Consultant Clinical Oncologist, Western General Hospital

Sue Farrington Smith, Chief Executive, Brain Tumour Research

Zoe Faulkner, Consumer Brain group, National Cancer Research Institute (NCRI)

Robin Grant, Western General Hospital

Sarah Jefferies, Addenbrooke’s Hospital NHS Foundation Trust

Michael Jenkinson, Clinical Senior Lecturer and Honorary Consultant Neurosurgeon, University of Liverpool

Juanita Lopez, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Cressida Lorimer, Clinical Research Fellow in Neuro-Oncology, Brighton and Sussex University Hospitals NHS Trust

Jillian Maclean, Consultant Clinical Oncologist, Velindre Cancer Centre

Paul Miller, NIHR Clinical Lecturer in Medical Oncology, University of Oxford

Samantha Mills, Neuroradiologist, Walton Centre

Meera Nandhabalan, Clinical Oncologist, Institute of Cancer Research (ICR)

Puneet Plaha, Surgeon, Oxford University Hospitals NHS Foundation Trust

Kieran Prior, Cancer Research UK (CRUK)

Faye Robertson, CRUK Clinical Research Fellow, University of Edinburgh

Thomas Santarius, Neurosurgeon, Addenbrooke’s Hospital NHS Foundation Trust

Stuart Smith, Clinical Associate Professor of Neurosurgery, University of Nottingham

Igor Vivanco, Team Leader in Molecular Addictions, Institute of Cancer Research (ICR)